Skip to main content
Fig. 4 | Cancer & Metabolism

Fig. 4

From: Transport-exclusion pharmacology to localize lactate dehydrogenase activity within cells

Fig. 4

TCA cycle labeling from U-13C lactate is decreased when whole cells are treated with oxamate, but not when whole cells are treated with GSK-2837808A. These results are consistent with oxamate (oxa) inhibiting cytosolic and mitochondrial LDH, but with GSK-2837808A (GSK) only inhibiting cytosolic LDH. HeLa cells were labeled with U-13C lactate for 24 h prior to analysis of whole-cell extracts by LC/MS. Data shown are averages from groups of n = 3. ***p < 0.001. n.s., no statistical significance. Left y axis shows labeling from 0 to 100%. Right y axis shows a zoomed-in scale for 13C isotopologues (inset)

Back to article page